IDEXX Laboratories Introduces “Suite Stories”—A Contest to Win the Next-Generation IDEXX VetLab® Suite [Trade]
Grand prize includes the Catalyst Dx™ and SNAPshot Dx™ Analyzers, arriving early 2008

Westbrook, Maine, June 18, 2007—IDEXX Laboratories, Inc. (NASDAQ:IDXX), announces “Suite Stories,” a contest for veterinary practices to win the next-generation IDEXX VetLab® Suite. The next-generation IDEXX VetLab® Suite includes two extraordinary new analyzers—Catalyst Dx™ and SNAPshot Dx™—which will upgrade the IDEXX VetLab® Suite and revolutionize veterinary diagnostics. Arriving in early 2008, the Catalyst Dx™ and SNAPshot Dx™ Analyzers will provide revolutionary convenience, ease-of-use, speed-to-result and high throughput, catalyzing the practice of medicine for more timely patient care and efficiency. Results are simply and seamlessly integrated through the IDEXX VetLab® Station for hematology, chemistry, electrolytes, endocrinology, urinalysis, blood gas and, soon, coagulation.

Any veterinary practice employee* in the United States can enter the contest by submitting stories explaining how their in-house laboratory made a difference for one or more patients. Participants who submit qualified entries will be eligible for a chance to win the grand prize next-generation IDEXX VetLab® Suite for their practice and one of many iPod-A-Day prize packages (2 GB iPod® nano and $25 iTunes® gift card) for themselves. The next-generation IDEXX VetLab® Suite is valued at approximately $50,000 USD and the iPod® prize package is valued at approximately $175 USD. Entries will be judged on originality, clarity, use of in-house diagnostic capabilities and case outcome. Seven semi-finalists will be chosen weekly and each will be awarded the iPod® prize package. At the end of the contest, twelve grand prize finalists will be chosen from the semi-finalists. The winner of the grand prize next-generation IDEXX VetLab® Suite will then be chosen from the semi-finalists. For the complete contest rules, visit www.suitestories.com/rules.

Completed entries submitted electronically at www.suitestories.com or by fax to 1-207-556-8889 must be received by 11:59 p.m. EST on September 30, 2007. Completed entries submitted by mail must be postmarked by September 30, 2007. Entries must be complete and will be accepted only on original entry forms or on official electronic or downloaded entry forms. Mail original or downloaded entries to: Suite Stories, c/o IDEXX Laboratories, One IDEXX Drive, Westbrook, Maine 04092.

For more information about the Suite Stories contest, please contact IDEXX at 1-207-556-8045 or 1-800-548-6733, ext. 68045, or visit www.suitestories.com.

*Entrants must be legal residents of the United States and practices must be located in the United States. iPod and iTunes are registered trademarks of Apple, Inc.

About the IDEXX VetLab Suite
The IDEXX VetLab® Suite of analyzers is trusted by more veterinarians worldwide to deliver increased confidence through more comprehensive, in-depth diagnostics. The suite provides flexibility in testing as well as efficiencies that minimize staff time and effort, offering in-house diagnostic capabilities for hematology, chemistry, electrolytes, endocrinology, urinalysis, coagulation and blood gas. The IDEXX VetLab® Station laboratory information management system integrates all results simply and seamlessly, including IDEXX SNAP® Test results, in one easy-to-use patient report for a complete picture of a patient’s health. All information is stored in the IDEXX VetLab® Station database for archiving and easy access to historical results for trends graphing.

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in companion animal health, serving practicing veterinarians around the world with innovative, technology-based offerings, including a broad range of diagnostic products and services, practice management systems and pharmaceuticals. IDEXX products enhance the ability of veterinarians to provide advanced medical care and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Westbrook, Maine, IDEXX Laboratories employs more than 4,000 people and offers products to customers in over 100 countries.

Note Regarding Forward-Looking Statements
This press release contains statements about the Company’s business prospects for future periods that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management’s expectations. Factors that could cause or contribute to such differences include the following: the Company’s ability to develop, manufacture, introduce and market new products and enhancements to existing products; the Company’s ability to integrate and operate acquired businesses; the effect of government regulation on the Company’s business, including government decisions about whether and when to approve the sale of the Company’s products and decisions regarding labeling, manufacturing and marketing of products; disruptions, shortages or pricing changes that affect the Company’s purchases of products and materials from third parties, including from sole source suppliers; the impact of distributor purchasing decisions on sales of our products that are sold through distribution; changes or trends in veterinary medicine that affect the rate of use of the Company’s products and services by veterinarians; the Company’s ability to obtain and maintain patent and other intellectual property protection for its products, successfully enforce its intellectual property rights and defend itself against third party claims against the Company; the effects of government regulatory decisions, customer demand, pricing and other factors on the realizability of the Company’s inventories; the Company’s ability to manufacture complex biologic products; the effects of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the loss of key employees. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2006 (1.5 MB), and Form 10-Q for the quarter ended March 31, 2007 (272 KB), in the section captioned "Risk Factors."

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe^® Reader^® software.